Skip to search formSkip to main contentSkip to account menu

PSI 697

Known as: PSI-697, PSI697 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Effect of PSI697, a Small Molecule Inhibitor of P-Selectin, in the Townes Model of Sickle Cell Disease
Chronic vaso-occlusion is a major cause of morbidity and mortality in patients with sickle cell disease (SCD). Persistent vaso… 
2013
2013
A Thought Experiment in Contemporary Drug Development: Informed Bench‐to‐Bedside Strategies
The evolution of drug development as a primary objective toward advancing patient well‐being is a fascinating illustration of… 
2009
2009
THE NOVEL P-SELECTIN INHIBITOR, PSI-697, REDUCES THROMBUS FORMATION IN AN EX-VIVO CLINICAL MODEL OF THROMBOSIS
Highly Cited
2007
Highly Cited
2007
Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulation
Summary P-selectin inhibition has been shown to decrease thrombogenesis in multiple animal species. In this study, we show that a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)